Thank you for the explanation! I sincerely appreciate, since I realized that my question could be perceived as trolling or nitpicking on the cost-effectiveness estimates. My intention is rather to understand better the impact of these interventions. Also, these DALY calculations are just hard (at least for me).
I think the answer makes sense.
Do you have a reference to the model that you’ve used (pardon if I missed the link)? I would be interested to look at it in a bit more detail. For example, my gut feeling is that a single or a few instances of IPV might already cause chronic damages; and so to avoid this damage we would be interested more in IPV-free lives than IPV-free years.
EDITED to add: On the other hand, it would seem likely that the effect of an intervention lasts for longer than a year, and thus that the beneficiaries would benefit from a reduced IPV risk for much of their lives.
Thank you for the explanation! I sincerely appreciate, since I realized that my question could be perceived as trolling or nitpicking on the cost-effectiveness estimates. My intention is rather to understand better the impact of these interventions. Also, these DALY calculations are just hard (at least for me).
I think the answer makes sense.
Do you have a reference to the model that you’ve used (pardon if I missed the link)? I would be interested to look at it in a bit more detail. For example, my gut feeling is that a single or a few instances of IPV might already cause chronic damages; and so to avoid this damage we would be interested more in IPV-free lives than IPV-free years.
EDITED to add: On the other hand, it would seem likely that the effect of an intervention lasts for longer than a year, and thus that the beneficiaries would benefit from a reduced IPV risk for much of their lives.